These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1413660)

  • 1. Transfusion results of filtered and subsequently stored random platelet suspensions prepared from buffy coats.
    Novotny VM; van Doorn R; Rozier Y; D'Amaro J; Harvey MS; Brand A
    Vox Sang; 1992; 63(1):23-30. PubMed ID: 1413660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
    Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
    Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Filtration. A method to prepare white cell-poor platelet concentrates with optimal preservation of platelet viability.
    van Marwijk Kooy M; van Prooijen HC; Borghuis L; Moes M; Akkerman JW
    Transfusion; 1990 Jan; 30(1):34-8. PubMed ID: 2296787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of leukocyte-depleted platelet concentrates for prevention of HLA-alloimmunization in patients with frequent platelet transfusions: a prospective multi-institutional study using a polyester platelet filter].
    Handa M; Ikeda Y; Kurata Y; Tsubaki K; Horiuchi A; Furihata K; Kimura Y; Toyama K; Takamoto S; Tsukimoto I
    Rinsho Ketsueki; 1992 Apr; 33(4):451-60. PubMed ID: 1602608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial.
    van Marwijk Kooy M; van Prooijen HC; Moes M; Bosma-Stants I; Akkerman JW
    Blood; 1991 Jan; 77(1):201-5. PubMed ID: 1984797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of leucocyte-poor platelet concentrates from buffy coats. IV. Clinical evaluation.
    Pietersz RN; Reesink HW; Huijgens PC; van Oers MH
    Vox Sang; 1988; 55(3):129-32. PubMed ID: 3070936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion of platelet concentrates from pooled buffy-coats: comparison of bedside vs. prestorage leukofiltration.
    Müller-Steinhardt M; Schlenke P; Wagner T; Klüter H
    Transfus Med; 2000 Mar; 10(1):59-65. PubMed ID: 10760204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vivo evaluation of random donor platelet concentrates from pooled buffy coats.
    Klüter H; Dörges L; Maass E; Wagner T; Bartels H; Kirchner H
    Ann Hematol; 1996 Aug; 73(2):85-9. PubMed ID: 8774617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preparation of leukocyte-depleted human platelet concentrates by centrifugation and filtration of a pool of sterilely connected buffy-coats].
    Angué M; Chatelain P; Domy M; Guignier F; Richaud P
    Rev Fr Transfus Hemobiol; 1991 Jan; 34(1):9-19. PubMed ID: 2015038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with transfusion of leukocyte-poor platelet concentrates prepared by filtration with prostacyclin.
    van Prooijen HC; Riemens TI; Akkerman JW
    Blood; 1987 Jul; 70(1):243-6. PubMed ID: 3297202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quality of thrombocyte preparations from buffy coat or platelet-rich plasma].
    Bux J; Müller K; Misterek J; Mueller-Eckhardt C
    Beitr Infusionsther; 1990; 26():99-102. PubMed ID: 1703912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of leukocyte-poor platelet concentrates for transfusion by filtration through a new cellulose acetate filter.
    Koerner K
    Haematologia (Budap); 1989; 22(3):181-8. PubMed ID: 2583598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of platelet loss during leukocyte reduction at 4, 24, and 48 hours postcollection using a Closed System Apheresis Kit with Integral filter.
    Jin YS; Mintz PD
    J Clin Apher; 1997; 12(1):14-7. PubMed ID: 9097230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.
    Trial to Reduce Alloimmunization to Platelets Study Group
    N Engl J Med; 1997 Dec; 337(26):1861-9. PubMed ID: 9417523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of leukocyte-poor platelets by filtration.
    Sniecinski I; Jean JS; Nowicki B
    J Clin Apher; 1989; 5(1):7-11. PubMed ID: 2777739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine levels as performance indicators for white blood cell reduction of platelet concentrates.
    Wadhwa M; Krailadsiri P; Dilger P; Gaines Das R; Seghatchian MJ; Thorpe R
    Vox Sang; 2002 Aug; 83(2):125-36. PubMed ID: 12201842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion experience with platelet concentrates stored for 24 to 72 hours at 22 degrees C. Importance of storage time.
    Lazarus HM; Herzig RH; Warm SE; Fishman DJ
    Transfusion; 1982; 22(1):39-43. PubMed ID: 7064205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial.
    van Rhenen D; Gulliksson H; Cazenave JP; Pamphilon D; Ljungman P; Klüter H; Vermeij H; Kappers-Klunne M; de Greef G; Laforet M; Lioure B; Davis K; Marblie S; Mayaudon V; Flament J; Conlan M; Lin L; Metzel P; Buchholz D; Corash L;
    Blood; 2003 Mar; 101(6):2426-33. PubMed ID: 12456508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
    Bertolini F; Rebulla P; Riccardi D; Cortellaro M; Ranzi ML; Sirchia G
    Transfusion; 1989 Sep; 29(7):605-9. PubMed ID: 2773027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of posttransfusion recoveries achieved with either fresh or stored platelet concentrates.
    Peter-Salonen K; Bucher U; Nydegger UE
    Blut; 1987 Apr; 54(4):207-12. PubMed ID: 3828538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.